Viveon Health Acquisition 's Income per employee grew in the first quarter 2023 on a trailing twelve month basis to , the contribution of Viveon Health Acquisition 's employees, reached a new high of $ 107,416income per employee.
The Healthcare sector has seen employees of 48 other companies achieving higher income per employee. While Viveon Health Acquisition 's total ranking has deteriorated compared to the previous quarter from 0 to 900.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VHAQ Net Income per Employee	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Net Income Change	-	-	-	-	-
Net Income per Employee (TTM) $	107,416	-55,027	-481,132	-157,456	-237,768
VHAQ's Total Ranking	# 900	# 0	# 0	# 0	# 0
Seq. Net Income Change	-90.71 %	-	-	-	-

VHAQ Company Profile >> Back to VHAQ Efficiency Comparisons >> Compare VHAQ Net Income per Employee to its Competitors

VHAQ Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 49
Healthcare Sector	# 78
Overall Market	# 900

Net Income per Employee Statistics
High	Average	Low
$ 107,416	$ -105,257	$ -381,904
(Mar 31 2023)		(Sep 30 2022)

Companies with similar Income per Employee for 12 month ending Mar 31 2023, within Healthcare Sector	Income per Employee	Income 12 month ending Mar 31 2023	Number of Employees Mar 31 2023
Merck and Co Inc	173,840.00	$ 13,038.000 Million	75,000
Exicure Inc	169,875.00	$ 1.359 Million	8
Oncotelic Therapeutics Inc	155,949.68	$ 5.926 Million	38
Precigen Inc	155,212.50	$ 24.834 Million	160
Zoetis Inc	142,620.69	$ 2,068.000 Million	14,500
Carlisle Companies Incorporated	141,033.90	$ 832.100 Million	5,900
Aspire Biopharma Holdings Inc	140,011.04	$ 6.300 Million	45
Abbvie Inc	133,210.53	$ 7,593.000 Million	57,000
Gyre Therapeutics Inc	129,370.55	$ 79.951 Million	618
Corcept Therapeutics Inc	129,175.34	$ 94.298 Million	730
Incyte Corporation	114,054.50	$ 324.371 Million	2,844
Eli Lilly And Company	113,736.00	$ 5,686.800 Million	50,000
Nkgen Biotech Inc	112,455.31	$ 2.924 Million	26
Celularity Inc	108,683.33	$ 13.042 Million	120
Viveon Health Acquisition Corp	107,416.36	$ 1.182 Million	11
Hologic Inc	106,506.36	$ 753.000 Million	7,070
Sensus Healthcare Inc	104,800.00	$ 6.288 Million	60
Utah Medical Products Inc	93,726.78	$ 17.152 Million	183
Edwards Lifesciences Corporation	93,050.00	$ 1,488.800 Million	16,000
Bio techne Corp	90,624.00	$ 271.872 Million	3,000
3m Company	90,396.69	$ 5,469.000 Million	60,500
Johnson and Johnson	90,369.32	$ 12,724.000 Million	140,800
Waters Corporation	87,195.82	$ 688.847 Million	7,900
American Bio Medica Corporation	85,000.00	$ 0.850 Million	10
Nrc Health	84,663.87	$ 30.225 Million	357
Iradimed Corporation	82,818.31	$ 13.748 Million	166
Supernus Pharmaceuticals inc	79,820.55	$ 52.043 Million	652
Intuitive Surgical Inc	78,479.53	$ 1,335.800 Million	17,021
Repligen Corp	77,166.00	$ 154.332 Million	2,000
Resmed Inc	75,897.36	$ 862.953 Million	11,370

Date modified: 2026-09-08T15:11:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.